Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotective Outcomes of Magnesium Sulfate in Neonates With Hypoxic-Ischemic Encephalopathy (HIE) at Tertiary Care Hospital of Karachi

NCT06342362 is registered in ClinicalTrials.gov with Sindh Institute of Child Health and Neonatology as lead sponsor.

NCT NCT06342362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotective Outcomes of Magnesium Sulfate in Neonates With Hypoxic-Ischemic Encephalopathy (HIE) at Tertiary Care Hospital of Karachi
Lead sponsor
Sindh Institute of Child Health and Neonatology
Phase
Phase 4
Overall status
Unknown status
Start date
April 2, 2024
Completion date
December 2, 2024
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonates with hie